Cargando…
Candesartan—the next anti-amyloid drug?
This scientific commentary refers to ‘Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer's disease’ by Hajjar et al. (https://doi.org/10.1093/braincomms/fcac270).
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683388/ https://www.ncbi.nlm.nih.gov/pubmed/36440098 http://dx.doi.org/10.1093/braincomms/fcac293 |